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Abstract 
A large body of empirical research shows that psychosocial risk factors (PSRFs) such 
as low socio-economic status, social isolation, stress, Type-D personality, depression and 
anxiety increase the risk of incident coronary heart disease (CHD) and also contribute to 
poorer health-related quality of life (HRQL) and prognosis in patients with established CHD. 
PSRFs may also act as barriers to lifestyle changes and treatment adherence and may 
moderate the effects of cardiac rehabilitation (CR). Furthermore, there appears to be a 
bidirectional interaction between PSRFs and the cardiovascular system. Stress, anxiety and 
depression affect the cardiovascular system through immune, neuroendocrine and 
behavioural pathways. In turn, CHD and its associated treatments may lead to distress in 
patients, including anxiety and depression. In clinical practice, PSRFs can be assessed with 
single-item screening questions, standardised questionnaires, or structured clinical interviews. 
Psychotherapy and medication can be considered to alleviate any PSRF-related symptoms 
and to enhance HRQOL, but the evidence for a definite beneficial effect on cardiac endpoints 
is inconclusive. A multimodal behavioural intervention, integrating counseling for PSRFs and 
coping with illness should be included within comprehensive CR. Patients with clinically 
significant symptoms of distress should be referred for psychological counseling or 
psychologically focused interventions and/or psychopharmacological treatment. To conclude, 
the success of CR may critically depend on the interdependence of the body and mind and 
this interaction needs to be reflected through the assessment and management of PSRFs in 
line with robust scientific evidence, by trained staff, integrated within the core CR team.  
Word count of abstract: 246 
Keywords: Cardiac rehabilitation; cardiovascular disease; coronary heart disease; 
psychological stress; risk factors; screening; treatment 
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Introduction 
In medical practice, “stress” is a common psychosocial complaint from patients,1 and 
the general public is increasingly concerned about the impact of psychosocial risk factors 
(PSRFs) on well-being and health.2 Many clinicians, especially in the field of cardiovascular 
medicine, tend to have given little attention to this topic,3 perhaps because “stress” and 
“psychosocial factors” are terms with conceptual ambiguity, but also because clinicians have 
limited familiarity with strategies to manage PSRFs.2-5 Nevertheless, the link between 
psychosocial stress and cardiovascular disease (CVD) has clearly been identified as an 
important public health concern.6 In addition, systematic reviews and meta-analyses of 
prospective aetiologic studies have shown that PSRFs, including low socio-economic status 
(SES),7,8 lack of social support,9 acute and chronic life stresses,10,11 anger and hostility,12 as 
well as anxiety13 and depression14 increase the risk of fatal and non-fatal CVD events, 
particularly incident coronary heart disease (CHD), and all-cause mortality. Likewise, and as 
will be further detailed below, PSRFs may adversely impact the prognosis of patients with 
clinically established CHD.3,4,15,16 
The INTERHEART case-control study, performed in 52 countries throughout Africa, 
Asia, Australia, Europe, the Middle East and North and South America, is one of the seminal 
studies that has been instrumental in increasing attention towards PSRFs in CVD.17 The study 
reported that perceived stress (due to work, home, finances or life events), and depression 
accounted for approximately 30% of the attributable risk of acute myocardial infarction (MI). 
The effects of PSRFs on acute MI were similar in men and women, all age groups, and all 
geographic regions of the world.17 As a consequence of this study and cumulative knowledge 
from over half a century of research, the importance of PSRFs, and their early recognition 
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and management, has been recognized in both previous and recent European guidelines on 
CVD prevention.18,19 
Knowing that the distinction between primary and secondary prevention of CHD is 
arbitrary in view of the underlying gradually developing atherosclerotic process, cardiac 
rehabilitation (CR) is an effective means for secondary prevention in patients with CHD.20 
CR represents an exercise-based multidisciplinary programme which aims to re-integrate 
patients with CHD, in particular after MI, into their former family, social and work-related 
lives and to support successful risk factor management, including lifestyle changes to 
decrease morbidity and mortality.20 The core components of CR and competencies of health 
care professionals working in CR are the optimization of cardioprotective therapies and 
medical and lifestyle risk factor management, including education, health behavior change 
and PSRF assessment and management.20,21 
A recent meta-analysis showed that exercise-based CR reduced depression and the 
risk of recurrent CHD events to a similar extent as did mental health treatments (i.e., 
psychotherapy and antidepressants), whereas reduction of total mortality was only achieved 
by CR.22 Exercise-based CR has also been shown to reduce anxiety.23 The mortality-lowering 
effects of exercise training during CR seems to be partially mediated by the beneficial effects 
of exercise on psychosocial stress, including symptoms of depression, anxiety, and hostility.24 
Therefore, the multidisciplinary approach of CR appears to be an ideal platform for PSRF 
management in patients with CHD. 
This position paper aims to briefly review the PSRFs relevant for the management 
and prognosis of patients with established CVD and to highlight the potential of CR to 
improve PSRF control and management. While different groups of CVD patients, including 
those with chronic heart failure,25 peripheral artery disease,26 and an implantable 
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cardioverter-defibrillator27, may all profit PSRF-wise from CR, this position paper focuses on 
psychosocial considerations in the rehabilitation of patients with uncomplicated CHD. 
Whereas there is a high level of evidence for the importance of PSRFs for 
cardiovascular health and prognosis3-5,15 and for their interaction with secondary prevention 
measures including CR,20,21 there is less scientific evidence regarding indications for and 
methods of screening or of the value of therapeutic interventions and their impact on 
prognosis. Therefore, this position paper reflects expert opinions on these aspects with the 
aim of (1) increasing awareness of the importance of PSRFs in the management of CVD, (2) 
providing an overview on different types of PSRF and their role in CR based on available 
evidence, and (3) making recommendations with respect to screening and management of 
PSRFs in the CR of CHD patients. By doing so, we acknowledge that position papers should 
be in agreement and consistent with guidelines covering a particular clinical topic28 in this 
case with the European guidelines on CVD prevention in clinical practice regarding PSRFs.19 
 
Psychosocial risk factors and stress 
There is no unifying theory about the definition of a “psychosocial factor” as a 
potential contributor to disease.2 Some authors propose to limit the term to psychological 
processes which develop from interactions between individuals and their social environment 
(e.g. social support, work stress), but not to include psychological characteristics which 
describe individuals (e.g. depression, hostility).2,29 This view bears conceptual appeal for the 
tailoring of interventions to target social circumstances influencing health in CR. On the other 
hand, many psychological characteristics that describe individuals co-exist with 
disadvantageous social circumstances.30,31 Therefore, this position paper applies an umbrella 
concept to the definition of PSRFs of CVD as is common practice in behavioral cardiology.3 
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Three categories of PSRFs for a poor prognosis in patients with uncomplicated CHD (the 
largest group treated in CR) can usually be distinguished. These categories relate to 
characteristics of the social environment, personality traits, and negative affect (Table 1).4 
PSRFs and psychological/psychosocial stress are sometimes used as mutually 
exchangeable constructs, but this does not serve well a scientific understanding of the concept 
of psychological stress.4 When talking about “stress”, a distinction must be made between 
“stressors”  as individually taxing situations and the “stress response” to these demands in 
cognitive, mental, behavioral, and physiological terms.5 A taxing or demanding situation will 
be appraised as irrelevant, challenging, or threatening, and be labeled as a “stressor” or not 
depending on the individual’s perceived competencies to control and manage it.32 As a result 
of several moderating factors, including genetic, biographical, demographic, personality (e.g., 
anger-proneness), and disease characteristics (e.g. pre-existing CHD), some individuals are 
more vulnerable than others to react to stress in a more intense or chronic manner than would 
be expected as an evolutionary beneficial fight-flight response.33 The neurobiological, 
neuroendocrine, and autonomic activation patterns accompanying maladaptive stress 
responses may bring forward dysfunctional cognitions (e.g. worrying), negative affect (e.g., 
depression, anxiety), poor health behaviors (e.g. unhealthy diet, sleep disturbances) and 
biological changes contributing to atherosclerosis (e.g. low-grade inflammation).34 The 
experience of symptoms of negative affect, such as symptoms of depression and anxiety, is 
sometimes captured as “psychological distress” which may also include somatic symptoms 
and social withdrawal.35 As such, high levels of in-hospital psychological distress after acute 
MI predicted cardiac mortality over the subsequent 5 years in men undergoing usual care, but 
not in those highly stressed patients who participated in a one-year programme of stress 
monitoring and intervention.36 
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The formulation of the above stress concept allows an assignment of different PSRFs 
to either the level of stressors (e.g. work stress) or the level of the stress response (e.g. 
depressive symptoms); it also allows a distinction between acute stress (e.g. traumatic 
experiences) and chronic stressors (e.g. work stress).4 In the CR setting, clinicians should be 
aware that when talking about “stress”, patients may refer to demanding life circumstances, 
unpleasant feelings or somatic symptoms.5 When assessed through simple self-report 
questions asking about the frequency and intensity of feeling stressed, perceived stress has 
been shown to predict incident CHD.37 However, to pinpoint the subjective meaning of what 
is meant by the word “stress”, the clinician needs to thoroughly assess illness perception and 
health beliefs of the patient.  
 
Linking psychosocial risk factors with coronary heart disease  
Behavioral and pathophysiological mechanisms interact and contribute to the 
initiation, progression, and clinical manifestation of atherothrombotic CVD.3,4,38 It is 
important to recognise the existence, interaction and relevance of these mechanisms (Table 
2)10,39-62 and of common genetic variants such as the serotonin transporter polymorphism or 
polymorphisms of inflammatory biomarkers which are linked to depression and CHD.64 
Whilst PSRFs such as anxiety and depression may affect the cardiovascular system through 
biological and behavioral pathways, it must also be emphasized that CHD and its treatments 
may, in turn, evoke stress65,66 and bring forth PSRFs like depression and posttraumatic stress 
disorder (PTSD).67,68 The impact of CHD on partners is important, as partners have the 
potential to affect patients’ responses to their diagnosis and management.67 Compared to 
usual care, a CR programme involving partners was shown to improve knowledge of heart 
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disease, reduce psychological distress, and improve satisfaction with care in both post-MI 
patients and their partners with a lasting effect at least up to one year.69  
Clustering of psychosocial and traditional risk factors of cardiovascular disease 
Psychosocial risk factors tend to cluster together and to co-occur with traditional risk 
factors of CVD.70 For instance, low SES is often associated with social isolation, depression 
and unhealthy lifestyle behaviors. Stress may be correlated with smoking, increased alcohol 
consumption and excessive body weight, those with low social support are less likely to stop 
smoking or adhere to medical regimens. The total CVD risk is reflected by the additive effect 
of traditional risk factors and PSRFs.71 
In cardiac prevention, PSRFs of CHD are usually given attention as distinct 
constructs,19 an approach that has been supported by several factor analyses.72-75 However, 
there also is substantial overlap in PSRFs, in particular along the negative affect spectrum, 
suggesting that there might be a general disposition toward negative affect that may be more 
important for CHD risk than any specific negative affect state.76,77 In agreement with this 
reasoning, an increasing number of studies suggest that combining PSRFs may increase their 
predictive value for the progression and poor prognosis of CHD.78-80 
 
Screening for psychosocial risk factors in cardiac rehabilitation  
The recently issued European guidelines on CVD prevention in clinical practice 
recommend based on the available evidence81-83 that PSRFs should be assessed and tailored 
clinical management should be considered in order to enhance health-related quality of life 
(HRQOL) and CHD prognosis.19 A recent meta-analysis showed CR significantly reduced 
depressive mood in patients with CHD.22 Studies on psychological interventions for CHD 
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patients in settings other than CR have found small-to-moderate improvements in depression 
and anxiety, a small reduction in cardiac mortality risk,84 and a reduction in all-cause 
mortality risk for men but not women.85 An assessment of PSRFs in patients with CHD is 
crucial as a means to stratify preventive efforts according to the individual risk profile of the 
patient. It is in keeping with good clinical practice to deliver a therapy only after a formal 
diagnosis has been made. Accordingly, individual psychotherapy sessions should be in line 
with the individual psychosocial needs and PSRFs of the patient. Moreover, it might not be 
ideal to address a PSRF in a group setting if some patients do not perceive that particular 
PSRF as being relevant to them, while high-risk patinets with regard to their PSRF profile 
can only be identified if screening is in place. In the case of clinically significant symptoms 
of depression, anxiety and hostility, psychotherapy, medication or collaborative care81,86 
could be considered to reduce mood symptoms and enhance HRQOL, but the evidence for a 
definite beneficial effect on cardiac endpoints is inconclusive.19 
It has been debated whether the cardiologist or other members of the multidisciplinary 
team are best placed to be trained to screen for PSRFs in CR.87,88 Our perspective is that the 
decision should depend upon each institution’s resources and preferences provided that 
adequate quality control is in place. As previously outlined,89 a two-step evaluation of PSRFs 
in CR is proposed: first, to ask the patient single-item questions about distinct PSRFs (Table 
3) and then to apply standardised questionnaires (Table 1).89 If potential psychosocial 
problems are identifed, patients should be referred to qualified health professionals (i.e. 
psychologists, behavioural experts) to establish diagnoses of, for instance, major depression 
or anxiety disorders (Table 1).4,89 There is no consensus about the most valid psychosocial 
evaluation instruments for this patient population90. However, evidence suggests that 
 11 
 
applying psychometric scales to assess PSRFs such as depression, anxiety, and anger/hostility 
provides useful information for CR.75 
It should be noted that a recent systematic review found no evidence that routine 
screening for depression in patients with CHD improves depression or cardiac outcomes, but 
randomized controlled trials on this issue are currently lacking.91 This review stated: 
“depression screening can benefit patients only to the extent that it identifies depressed 
patients not already diagnosed or treated for depression, successfully enrolls those patients 
in treatment, and achieves positive treatment results.91” Therefore, it is highly desirable that 
routine screening for PSRFs translates into improved healthcare models.19 Future research is 
clearly needed to determine whether screening for PSRFs improves HRQOL and other 
outcomes in CR patients. 
 
Core competencies to manage psychosocial risk factors in cardiac rehabilitation 
The professional knowledge and skills needed for the effective management of PSRFs 
in patients with stable CHD in CR have been proposed in previous position papers.20,21 Core 
competencies should include a screen for stress and PSRFs to identify clinically relevant 
levels of depression, anxiety, anger/hostility, relationship stress and low social support. 
Patients with CHD often have difficulty in communicating their stress and have identified 
gaps in the professional support available to help them to address stressors.92,93 Stress 
management should be offered to patients on an individual basis or in small groups. 
Whenever possible, significant others should be included and patients should be helped to 
obtain effective social support. In case of work stress, vocational counseling should be 
provided. Referrals to psychiatric or other behavioral healthcare providers are to be 
considered if patients’ needs are beyond the scope of the psychosocial care that can be 
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offered in the context of CR.21 Strategies to effectively change unfavorable health behaviors 
should integrate best research with clinical expertise and take account of patients’ needs and 
preferences.21 The expected outcomes of psychosocial management in CR are absence of 
clinically relevant psychosocial problems and acquisition of stress management skills,20 
enhanced HRQOL and improved CHD prognosis.19 It has been shown that, after only two 
half-day sessions of psychosocial management training, CR staff gain significant knowledge 
in psychosocial issues and cognitive behavioral treatment techniques.87 
Educational interventions can affect a patient’s psychological state positively and 
reduce misconceptions about CHD and its outcomes.20,94 Frank discussions of the patient’s 
concerns, fears and health beliefs are helpful. Group sessions, led by trained mental health 
specialists, allow patients to share common concerns, provide mutual support, obtain 
educational information and receive guidance regarding the progressive resumption of 
activities. Individual counseling sessions by trained psychologists or other mental health 
professionals are more specific, tailored to the individual’s problems and can apply 
educational elements. 
In summary, there is a clear need for CR programmes to screen for PSRF and to have 
established links with mental health care professionals (i.e. psychologists, psychiatrists or 
experts in psychosomatic medicine). Ensuring that at least one CR team member has special 
training related to mental health issues would improve levels of relevant expertise on PSRF 
assessment and management within CR and would likely lead to better patient outcomes. 
 
Synopsis of psychosocial risk factors for poor prognosis of coronary heart disease 
In the following paragraphs, we describe individual PSRFs for adverse outcomes in 
patients with established CHD and then weight their impact on CHD prognosis through data 
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from systematic reviews and meta-analyses or individual prognostic studies. We also provide 
suggestions for the screening and assessment of PSRFs with single-item questions, 
standardized and validated questionnaires, and clinical interviews.89 Finally, we selectively 
review the literature about the effects of CR on PSRFs. It is beyond the scope of this position 
paper to discuss studies which probed for an effect of biobehavioural interventions on PSRFs 
and CVD risk outside the CR setting.  
 
Acute and Chronic Stress 
Intense emotions like outbursts of anger95 and acute life "stressors" commonly 
accompanied by intense emotions can trigger cardiovascular events and increase mortality 
within a few hours to several months, e.g. following the death of a loved one,96,97 natural 
disasters,98 military/ terrorist attacks,99 or even major football tournaments.100,101 The 
triggering of acute coronary syndromes as well as fatal arrhythmias and sudden cardiac death 
is particularly observed in patients with pre-existent CHD.98,102 
There also is an association between stressful life events such as financial strain and 
recurrent CHD events among women.103 Moreover, compared to men with CHD, women 
with CHD reported more stressful life events and other PSRFs in the year following hospital 
discharge.104 Financial stress and social isolation predicted worsening of depression and 
persistent anxiety.104 Hence patients with these PSRFs and female patients might constitute 
high-risk CHD patients who might particularly benefit from CR.102,105 
Concern is increasing about the adverse effects of chronic work stress, particularly on 
CHD risk.11 Two models identifying stressful components of the psychosocial work 
environment have received particular attention, that is the job strain model (high work 
demands and low job control) and the effort-reward imbalance model (high efforts and low 
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reward).106,107 Cross-sectional findings controlling for age, gender, and socio-economic status 
(SES) show people with job strain are more likely to have traditional CVRFs, including 
diabetes, smoking, physical inactivity, and obesity.108 Nonetheless, independent of traditional 
CVRFs, in patients who returned to work after a first MI, chronic job strain was a prognostic 
factor for recurrent CHD events,109 and effort/reward imbalance predicted poor prognosis in 
women.110 
 
Consequences for cardiac rehabilitation 
Exposure to chronic or acute stress has to be assessed formally not only as a potential 
risk factor for CVD but also as a barrier for successful treatment and lifestyle changes in CR. 
For individual patients, it may be more important to change their existing stressors, or to 
enhance their coping mechanisms for existing stressors, than to change unhealthy lifestyle 
habits. Therefore, it is essential to identify stressors with patients and support them in finding 
ways to attenuate stressors. This ideally should be carried out by trained personnel in 
dedicated sessions dealing with stress. Stress management can be a first line intervention but 
may also be a prerequisite for successful, sustained CR and secondary prevention. It has been 
shown that job stressors can successfully be reduced through CR.111  
 
Social factors  
Low SES such as indexed by low income, education, and occupational class (e.g., 
manual vs. non-manual), is a major contributor to health inequalities world-wide,112 including 
lower survival in those with CHD.113 Post-MI patients with both low income and low 
education are particularly at risk of premature mortality.114 Whilst some components of SES 
are not modifiable, CR can address some of the correlates, such as functional recovery and 
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traditional CVRFs which have been shown to account for much of the association between 
low SES and mortality after MI.115,116 
Social support is a function of the breadth of an individual’s social network as well as 
the perceived benefit reaped from their network‘s members. A meta-analysis showed that low 
functional support more than low structural support (i.e. the size of the social network) 
predicts an increase in risk of cardiac and all-cause mortality controlling for other prognostic 
factors in patients with CHD.9 Although low social support and depression are often found in 
combination, a very high level of social support may serve as a buffering variable against the 
impact of depression on mortality in post-MI patients,117 although these data are not 
uniform.118 
Social support during CR can stem from various sources such as health professionals, 
family members, and employers 119 and, by its association with depression may contribute to 
post-rehabilitation QoL.120 Marital and family concerns should be addressed in support 
interventions.121 Marriage satisfaction was higher in CHD patients who participated in CR 
compared to non-participants.122 Perceived employer support, more than family and physician 
support, predicted better work adjustment in CR patients123 and social support has also been 
associated with higher exercise tolerance in CHD patients during CR.124 However, whilst in 
the randomised controlled ENRICHD trial, a cognitive behavioral therapy-based 
psychosocial intervention increased social support in post-MI patients with low perceived 
social support, this effect did not translate into better cardiac outcomes.125 
 
Consequences for cardiac rehabilitation 
In CR it is important to assess SES and, in particular, address the issue of social 
support. Measurement of the latter is variable and a multidimensional approach is 
 16 
 
proposed.119 All actions that appear to pragmatically attenuate individual social stressors in 
CR should be considered as therapeutic and preventive. Participation in long-term supervised 
exercise training groups (“heart clubs”) or other outpatient prevention groups may provide 
social contact that actively enhances social support and reduces social isolation. 
 
Personality factors  
Various personality types or characteristics have been considered over time as being 
risk factors for CHD: these include the Type A behavior pattern and Type D personality as 
well as anger-proneness and hostility. 
The Type A “coronary prone” behavior pattern includes ambitious and competitive 
behaviour, impatience, hostility and intolerance. Early findings of an association between 
Type A behaviour and CHD126,127 were challenged by more recent studies128,129 and a meta-
analysis concluding that Type A behaviour has no impact on the development of CHD.130 
While there is little evidence that Type A personality is a prognostic factor in patients with 
CHD,131 it may be a risk marker for psychological distress.132 About 25% of patients in CR 
with a recent MI present with Type A behaviour,133 and CR programmes targeting type A 
behaviour may reduce psychological distress.134 
Anger-proneness and hostility have been identified as the “pathogenic” components 
of the Type A personality behaviour pattern, and they negatively impact on both CHD 
development and prognosis in patients with CHD.12 Hostility can be described as a cognitive 
attitude of cynical and suspicious thinking about others. There is some overlap between 
hostility and anger-proneness; hostile behaviours may show in overt expression of angry 
feelings and verbal aggressiveness.4 CR may decrease hostility and anger significantly.135,136 
Hostility has been shown to contribute to lower baseline and follow-up HRQOL in CR.120 A 
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reduction in psychological stress, including symptoms of hostility, through exercise-based 
CR, has been shown to explain, in part, a reduced mortality risk for  CHD patients.24 
Type D personality is characterised by increased levels of negative emotions (i.e., 
negative affectivity), such as worrying, depressive feelings and irritability, with a greater use 
of maladaptive coping strategies plus a tendency towards social inhibition and isolation.137,138 
Type D is present in approximately one third of patients with CVD. It seems to be 
significantly more prevalent in hypertensive patients (53%) than in CHD patients (28%) and 
healthy controls (20%).138 Multiple studies and meta-analyses have shown that patients with 
this personality profile and with established CVD have a poorer prognosis than non-Type D 
patients.139-141 However, some of the more recent studies failed to find a prognostic value of 
Type D personality for poor outcome in cardiac patients.142,143 Type D personality has also 
been associated with impaired patient-reported physical and mental health status in patients 
with CVD.144 A CR programme focusing on Type D characteristics led to reduced Type D 
scores at the one-year follow-up in CHD patients who had high baseline scores: this effect 
was attributed mainly to a reduction in social inhibition.145 Another, although uncontrolled, 
study found CR decreased social inhibition scores to a greater extent in women than in men 
with CHD.146 Compared to non-Type D’s, Type D patients were shown to benefit less from 
CR in terms of psychological well-being, including depressive mood and anxiety.137 
 
Consequences for cardiac rehabilitation 
Evaluation of personality factors may be important in the secondary prevention of 
CHD and direct psychological intervention focusing on anger and hostility may be 
appropriate. The prognostic effect of such interventions has not been studied systematically 
in CR. Thus a strong recommendation to include these in CR cannot be made. Few studies 
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have investigated Type D patients following CR but where they have, it has been shown that 
many of these patients, despite an overall improvement in psychological well-being, continue 
to show clinically relevant levels of anxiety, depression, impaired psychophysical well-being, 
perceived psychophysical stress, interpersonal difficulties and social anxiety. To date, there is 
no scientific evidence regarding how best to treat type D patients with these characteristics.  
 
Negative affect  
Anxiety: A recent meta-analysis including post-MI patients demonstrated that anxiety 
symptoms were predictive for all-cause mortality, cardiac mortality and new cardiac events 
over an average follow-up period of 3 years.147 Most of the included studies had assessed 
anxiety symptoms with the State Trait Anxiety Inventory (STAI) or the anxiety subscale of 
the Hospital Anxiety and Depression Scale (HADS-A).147 More recently, cardiovascular 
prognosis was also found to be impaired in CHD patients with, versus those without, a 
general anxiety disorder.148  
Regarding the prevalence of clinically significant anxiety in CHD populations, a 
prospective study on patients with acute MI showed elevated STAI scores in 27%, 42%, and 
40%, respectively, during hospitalisation, after 4 months and after one year.149 In another 
study, 29% of patients were identified with anxiety or depression or both, according to the 
HADS, at three months after a first MI.150 Of these, only 30% and 21% respectively had 
received psychosocial support or used antidepressants, indicating that there is a need for 
longer-term CR with a focus on mental health issues.150 Further work reported that 45% of 
CHD patients commencing CR had at least one anxiety disorder and the majority of those 
with a depressive disorder also had an anxiety disorder.151 The prevalence of clinically 
significant symptoms of a PTSD attributable to the traumatic experience of an acute coronary 
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event is 16%; there is cumulative evidence that PTSD symptoms also worsen the 
cardiovascular prognosis in patients with CHD.152 
Exercise- and educationally-based CR, including lectures on psychological distress 
and teaching of stress-reduction techniques have markedly reduced symptoms of anxiety with 
greatest improvements seen in those with high levels of anxiety.23 Compared to in-hospital 
anxiety levels, anxiety scores, measured with the HADS, had significantly decreased after18 
months in women who had participated in formal CR compared to those who had not.153 
Other controlled studies also showed CR to significantly reduce anxiety in CHD 
patients.122,135 Compared to older women, younger women showed higher anxiety levels at 
the start of CR,127 and higher baseline anxiety and depression scores were found in defaulters 
of CR than in completers.154  
 
Consequences for cardiac rehabilitation 
The onset of a cardiac event, sudden disease progression and acute hospitalisation to 
an intensive care unit or cardiac surgery can be frightening and stressful.67 The initial reaction 
to MI in many patients comprises feelings of anxiety, and this is a normal human reaction; 
however, very high levels of distress related to fear of dying and helplessness may impact 
prognosis after MI in their own right.66 Some patients may be anxious about their prognosis, 
and about possible physical, sexual, social and occupational incapacity. Some may avoid any 
physical activity, emotional exertion, sex and other activities, fearing that these may be 
harmful to their health. Therefore, assessing anxiety at the beginning of CR is important. 
Despite recent critique,155 the HADS is a standardized, validated, and frequently used 
questionnaire for the assessment of anxiety and/or depression.156 However, it is probably 
 20 
 
more effective in measuring general psychological/emotional distress than in clearly 
differentiating between symptoms of anxiety and depression in CVD patients.157 
Depression: An overview of the literature on the depression-CHD link from the last 
25 years concluded from about 50 prognostic studies that depression is associated with a 1.6-
to 2.2-fold increased risk of adverse outcomes;158 this result is bolstered by several systematic 
reviews and meta-analyses of the last decade of research.9,14,159,160 Poor outcomes relate to 
significantly higher rates of future cardiac events, including re-infarction, cardiac arrest and 
cardiac mortality, including sudden death. Cardiac disease severity and other prognostic 
factors like health behaviors may account for some of this risk.158,161 A recent meta-analysis 
showed that somatic/affective symptoms of depression (e.g. sleep and fatigue) have a greater 
predictive value for cardiovascular prognosis in CHD patients than cognitive/affective 
symptoms (e.g. sad mood).162 
Depression is associated with increased dropout rates from CR154 and at least three 
times more common in patients after acute MI than in the general population.159 About 15-
25% of patients with MI meet the Diagnostic and Statistical Manual of Mental Disorders 
Fourth Edition (DSM-IV) criteria for major depression, and even a higher proportion (40-
65%) show elevated levels of depressive symptoms.163,164 National Health Interview Survey 
data of 30,801 adults found the 12-month prevalence of major depression to be 9.3% in 
individuals with cardiac disease compared with 4.8% in those without comorbid medical 
illness.165 Also, depression in the general population and among CHD patients is twice as 
common in women than in men.166 Recent evidence suggests that young women may be at 
particularly high risk for depression after acute MI.167 
Patients with CHD and depression have more severe cardiac symptoms, adhere less to 
medical therapy and CR and have slower resumption of activities and social readjustment, 
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with lower rates of return to work and poorer HRQOL following MI and bypass surgery.40,41 
The prevalence of depression and depressive symptoms in patients hospitalized for unstable 
angina, angioplasty, bypass surgery, and valve surgery are similar to those observed in 
patients with MI, and are even higher than in CHD patients with congestive heart 
failure.168,169 Depression immediately before and after bypass surgery is linked to higher rates 
of re-hospitalisation, longer recovery and surgical complications, lower HRQOL and slower 
return to work.165 The coexistence of depression with CHD is associated with more frequent 
emergency department and ambulatory care visits, more days spent in bed because of illness, 
functional disability and additional health care costs.165 Studies on the effect of depression on 
prognosis in CR patients are rare but one study which compared CHD patients with and 
without depression after CR, showed that those with depression had markedly higher 
mortality after 4 years of follow-up.170 
 
Consequences for cardiac rehabilitation 
Depression and depressive symptoms are highly relevant to CR. The most widely 
used screening tools for depression are the HADS156 and the Patient Health Questionnaire 
(PHQ).171 The PHQ-2 provides 2 questions, recommended for screening for current 
depression: if the answer is “yes” to both questions, a full psychological assessment is 
recommended.172 Identifying and treating depression and/or depressive symptoms is a major 
challenge. Treatment options include psychological counseling (including cognitive-
behavioral therapy), antidepressants (primarily selective serotonin reuptake inhibitors) and 
physical activity.84,173 In patients with CHD and elevated depressive symptoms, four months 
of aerobic exercise training  three times/week was shown to be as effective as antidepressants 
for improving depressed mood.174 However, while psychological and antidepressant treatment 
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can reduce depressive symptoms, their impact on the reduction of cardiac mortality, rate of 
MI, need for cardiac surgery or reduction of total mortality is less clear.22,84.175,176 
 
Health-related quality of life 
Despite that HRQL is not understood as a PSRF, it is a well defined predictor of mortality 
in patients with CHD,177 and its improvement is considered a desirable outcome parameter of 
CR, reflecting patients’ physical and psychological well-being. In recent years HRQOL and 
patient-reported health status have gained considerable interest on various levels.178 Cardiac 
patients with poor self-reported HRQOL tend to have higher rates of re-infarction and re-
hospitalisation,179,180 and they are less likely to be invited to, or to attend CR.181 A systematic 
review clearly demonstrates that CR improves HRQOL,182 and, for patients with elevated 
depressive mood, there was greater improvement in physical quality of life during CR if they 
were provided stress management in addition to exercise than exercise only.183 Better baseline 
scores of HRQOL predicted fewer early dropouts from CR, although this effect was not 
independent of other variables.184 Notably, a CR programme tailored for women significantly 
improved global HRQOL compared with traditional CR.185 Comorbid psychiatric disorders 
and the distressed (Type D) personality are both associated with diminished HRQOL in CR 
populations.151,137  
 
Consequences for cardiac rehabilitation 
As CR aims to ultimately improve a patient’s HRQOL, it is important to assess their 
HRQOL status and to monitor it during the programme. Readily available valid and reliable 
intruments for this puropose are the Dartmouth COOP, the MacNew, and the Kansas City 
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Cardiomyopathy Questionniare.186-188 A newer instrument - the HeartQoL questionnaire 
provides a single reliable and valid core CHD-specific tool for comparing HRQOL outcomes 
in patients with CHD across European language groups. HeartQoL comprises 14-items (10-
item physical and a 4-item emotional subscales with a global score if needed. An 
international cohort of 6384 patients, from 22 countries, speaking one of 15 languages 
provided the basic psychometric basis for the measure.189,190 It should be noted that different 
questionnaires assess different aspects of QoL so that the changes in HRQOL during CR will 
depend on the type of instrument used and the patient’s baseline status.120,191  
 
Conclusions 
Research in recent decades has demonstrated that PSRFs, such as low SES, lack of 
social support, chronic stress, anger and hostility, Type D personality, anxiety and depression 
are associated with adverse patient and clinical outcomes in patients with established CHD. 
Core behavioural factors related to an unhealthy lifestyle, pathophysiological mechanisms 
and poor adherence to therapy may contribute to this association. A goal of CR is to identify 
patients with PSRFs and offer tailored interventions by a core CR team, including expertise 
in psychosocial care. In general, psychological support is intended to reduce cardiovascular 
risk, improve HRQOL, and facilitate the patient’s return to regular family, social and work-
related life. It should be a component of every CR programme and delivered in line with 
robust scientific evidence by trained staff.  
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Table 1. Psychosocial risk factors for poor prognosis in patients with coronary heart 
disease patients 
Risk factor Relevance for 
prognosis 
Psychometric assessment Effect of cardiac 
rehabilitation 
Low socioeconomic 
status 
++ Hollingshead Two-Factor Index 
of Social Position192 
Not directly 
influenced 
Low social support +++ ENRICHD Social Support 
Inventory (ESSI, 7 items)193 
Positive 
Work stress + Job Content Questionnaire (JCQ, 
42 items)194 
Effort-Reward Imbalance 
questionnaire (ERI, 23 items) 107 
Probably positive 
Anger and hostility + Strait Trait Anger Inventory 
(STAXI, 44 items)195 
Cook-Medley Hostility Scale (CM 
Ho Scale, 50 items)196 
Positive 
Type D personality ++ Type D Scale-14 (DS 14, 14 
items)148 
Probably positive 
Depression +++ Hospital Anxiety and Depression 
Scale (HADS, 7 items)156 
Patient Health Questionnaire-9 
Clearly positive 
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(PHQ-9, 9 items)197 
Beck Depression Inventory (BDI, 
21 items)198 
Composite International 
Diagnostic Interview (CIDI)199 
Anxiety ++ Hospital Anxiety and Depression 
Scale (HADS, 7 items)156 
State-Trait Anxiety Inventory 
(STAI, 40 items)200 
Composite International 
Diagnostic Interview (CIDI)199 
Clearly positive 
 
Level of importance: +++ high, ++ medium, + low 
The time required to administer the above questionnaires is between 5 and 15 min and time 
for staff to score them between 1 and 10 min. Except the questionnaires for work stress, all 
others provide clinical cutoffs.89 
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Table 2. Mechanisms linking psychosocial factors with coronary heart disease  
 
 
 
 
 
Behavioral mechanisms 
• unhealthy lifestyle (unhealthy diet, 
smoking, drinking excess alcohol, 
being sedentary)39,40 
• reduced chances of successful 
modification of risk factors (such as 
smoking cessation)39,41 
• decreased adherence to medical 
treatment regimens42-45 
• lower rates of participation in 
cardiac rehabilitation and reduced 
quality of life46-49 
 
Pathophysiological mechanisms 
• hypothalamic-pituitary-adrenal axis and autonomic 
nervous system dysfunction: increased sympathetic 
activity and/or reduced vagal activity, 
hypercortisolemia with raised corticotropin-releasing 
factor (increased free fatty acids); reduced heart rate 
variability50-52 
• reduced serotonin, leading to platelet dysfunction, 
hyperactivity53,54 and hypercoagulability55 
• Ω-3 fatty acid deficiency56,57 
• elevated homocysteine levels56 
• endothelial dysfunction58,59 
• stress-induced myocardial ischemia60,61 
• elevated inflammatory biomarkers (C-reactive 
protein, interleukin-6, intercellular adhesion 
molecule-1)62.63 
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Table 3. Simple screening questions to identify potential psychosocial problem areas 
Psychosocial risk factor Closed questions (yes/no answers) 
Low socioeconomic status Do you have more than the mandatory level of education?                                       
Are you a manual worker? 
Low social support Are you living alone? Do you have a close confidant?                            
Do you have any person to help you in case of illness?                            
Do you have serious problems with your partner? 
Work stress Do you have enough control over how to meet the demands at 
work?  
Is your reward appropriate for your effort? 
Hostility/anger Do you frequently feel angry over little things?                                         
If someone annoys you, do you regularly let him or her know?                         
Do you often feel annoyed about habits other people have? 
Depression During the past month, have you often been bothered (i) by feeling 
down, depressed, or hopeless? (ii) by little interest or pleasure in 
doing things? 
Panic-like anxiety During the past month, have you had an anxiety attack, i.e., 
suddenly feeling fear or panic? 
Posttraumatic stress During the past month, have you experienced the following 
regarding your heart disease: (i) that you had nightmares about it or 
thought about it when you did not want to? (ii) tried hard not to 
think about it or to avoid situations that reminded you of it? 
 
